nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLCO4C1—Methotrexate—multiple sclerosis	0.255	0.325	CbGbCtD
Saxagliptin—ABCC1—Mitoxantrone—multiple sclerosis	0.166	0.212	CbGbCtD
Saxagliptin—ABCC1—Methotrexate—multiple sclerosis	0.0692	0.0883	CbGbCtD
Saxagliptin—SLC22A8—Methotrexate—multiple sclerosis	0.0538	0.0686	CbGbCtD
Saxagliptin—CYP3A4—Fingolimod—multiple sclerosis	0.0511	0.0651	CbGbCtD
Saxagliptin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0329	0.042	CbGbCtD
Saxagliptin—CYP3A5—Dexamethasone—multiple sclerosis	0.0319	0.0407	CbGbCtD
Saxagliptin—CYP3A4—Triamcinolone—multiple sclerosis	0.0249	0.0318	CbGbCtD
Saxagliptin—CYP3A4—Mitoxantrone—multiple sclerosis	0.024	0.0306	CbGbCtD
Saxagliptin—CYP3A4—Betamethasone—multiple sclerosis	0.0214	0.0273	CbGbCtD
Saxagliptin—CYP3A4—Prednisolone—multiple sclerosis	0.0211	0.0269	CbGbCtD
Saxagliptin—CYP3A4—Prednisone—multiple sclerosis	0.0199	0.0254	CbGbCtD
Saxagliptin—CYP3A4—Dexamethasone—multiple sclerosis	0.0124	0.0159	CbGbCtD
Saxagliptin—Fracture—Betamethasone—multiple sclerosis	0.0018	0.00857	CcSEcCtD
Saxagliptin—Fracture—Dexamethasone—multiple sclerosis	0.0018	0.00857	CcSEcCtD
Saxagliptin—Multiple fractures—Betamethasone—multiple sclerosis	0.0018	0.00857	CcSEcCtD
Saxagliptin—Multiple fractures—Dexamethasone—multiple sclerosis	0.0018	0.00857	CcSEcCtD
Saxagliptin—Lymphopenia—Prednisone—multiple sclerosis	0.00178	0.00847	CcSEcCtD
Saxagliptin—Purpura—Cladribine—multiple sclerosis	0.00175	0.00833	CcSEcCtD
Saxagliptin—Hypertriglyceridaemia—Prednisone—multiple sclerosis	0.00158	0.00755	CcSEcCtD
Saxagliptin—Fracture—Prednisone—multiple sclerosis	0.00156	0.00746	CcSEcCtD
Saxagliptin—Multiple fractures—Prednisone—multiple sclerosis	0.00156	0.00746	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00151	0.00722	CcSEcCtD
Saxagliptin—Infection—Fingolimod—multiple sclerosis	0.00145	0.00692	CcSEcCtD
Saxagliptin—Skin disorder—Fingolimod—multiple sclerosis	0.00142	0.00677	CcSEcCtD
Saxagliptin—Blood triglycerides increased—Prednisone—multiple sclerosis	0.00139	0.00662	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00135	0.00645	CcSEcCtD
Saxagliptin—Fracture—Methotrexate—multiple sclerosis	0.00131	0.00624	CcSEcCtD
Saxagliptin—Multiple fractures—Methotrexate—multiple sclerosis	0.00131	0.00624	CcSEcCtD
Saxagliptin—Infestation NOS—Cladribine—multiple sclerosis	0.0013	0.00619	CcSEcCtD
Saxagliptin—Infestation—Cladribine—multiple sclerosis	0.0013	0.00619	CcSEcCtD
Saxagliptin—Urinary tract infection—Cladribine—multiple sclerosis	0.00126	0.00602	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00126	0.00601	CcSEcCtD
Saxagliptin—Fatigue—Fingolimod—multiple sclerosis	0.00126	0.006	CcSEcCtD
Saxagliptin—Pancreatitis—Azathioprine—multiple sclerosis	0.00116	0.00553	CcSEcCtD
Saxagliptin—Oedema peripheral—Cladribine—multiple sclerosis	0.00115	0.00547	CcSEcCtD
Saxagliptin—Infestation—Azathioprine—multiple sclerosis	0.00105	0.00503	CcSEcCtD
Saxagliptin—Infestation NOS—Azathioprine—multiple sclerosis	0.00105	0.00503	CcSEcCtD
Saxagliptin—Immune system disorder—Cladribine—multiple sclerosis	0.00105	0.00502	CcSEcCtD
Saxagliptin—Asthenia—Fingolimod—multiple sclerosis	0.00105	0.005	CcSEcCtD
Saxagliptin—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.00104	0.00495	CcSEcCtD
Saxagliptin—Pruritus—Fingolimod—multiple sclerosis	0.00103	0.00493	CcSEcCtD
Saxagliptin—Malnutrition—Cladribine—multiple sclerosis	0.00101	0.00484	CcSEcCtD
Saxagliptin—Flatulence—Cladribine—multiple sclerosis	0.000999	0.00477	CcSEcCtD
Saxagliptin—Dizziness—Fingolimod—multiple sclerosis	0.000965	0.00461	CcSEcCtD
Saxagliptin—Headache—Fingolimod—multiple sclerosis	0.000914	0.00436	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.000889	0.00424	CcSEcCtD
Saxagliptin—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.000881	0.0042	CcSEcCtD
Saxagliptin—DPP8—medulla oblongata—multiple sclerosis	0.000875	0.135	CbGeAlD
Saxagliptin—Purpura—Triamcinolone—multiple sclerosis	0.000866	0.00413	CcSEcCtD
Saxagliptin—Myalgia—Cladribine—multiple sclerosis	0.000863	0.00412	CcSEcCtD
Saxagliptin—Arthralgia—Cladribine—multiple sclerosis	0.000863	0.00412	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000857	0.00409	CcSEcCtD
Saxagliptin—Immune system disorder—Azathioprine—multiple sclerosis	0.000855	0.00408	CcSEcCtD
Saxagliptin—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.000829	0.00396	CcSEcCtD
Saxagliptin—Infection—Cladribine—multiple sclerosis	0.000822	0.00392	CcSEcCtD
Saxagliptin—Thrombocytopenia—Cladribine—multiple sclerosis	0.00081	0.00387	CcSEcCtD
Saxagliptin—Skin disorder—Cladribine—multiple sclerosis	0.000804	0.00383	CcSEcCtD
Saxagliptin—DPP8—midbrain—multiple sclerosis	0.0008	0.123	CbGeAlD
Saxagliptin—Sinusitis—Mitoxantrone—multiple sclerosis	0.0008	0.00382	CcSEcCtD
Saxagliptin—DPP8—spinal cord—multiple sclerosis	0.000781	0.12	CbGeAlD
Saxagliptin—Pancreatitis—Prednisolone—multiple sclerosis	0.000769	0.00367	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000754	0.0036	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000714	0.00341	CcSEcCtD
Saxagliptin—Fatigue—Cladribine—multiple sclerosis	0.000713	0.0034	CcSEcCtD
Saxagliptin—Pancreatitis—Triamcinolone—multiple sclerosis	0.000707	0.00338	CcSEcCtD
Saxagliptin—Pancreatitis—Methylprednisolone—multiple sclerosis	0.000706	0.00337	CcSEcCtD
Saxagliptin—Myalgia—Azathioprine—multiple sclerosis	0.000702	0.00335	CcSEcCtD
Saxagliptin—Arthralgia—Azathioprine—multiple sclerosis	0.000702	0.00335	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000697	0.00333	CcSEcCtD
Saxagliptin—Purpura—Prednisone—multiple sclerosis	0.000684	0.00327	CcSEcCtD
Saxagliptin—DPP9—cerebellum—multiple sclerosis	0.00068	0.105	CbGeAlD
Saxagliptin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000677	0.00323	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000671	0.0032	CcSEcCtD
Saxagliptin—Infection—Azathioprine—multiple sclerosis	0.000668	0.00319	CcSEcCtD
Saxagliptin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000659	0.00314	CcSEcCtD
Saxagliptin—Urticaria—Cladribine—multiple sclerosis	0.000657	0.00314	CcSEcCtD
Saxagliptin—Abdominal pain—Cladribine—multiple sclerosis	0.000654	0.00312	CcSEcCtD
Saxagliptin—Skin disorder—Azathioprine—multiple sclerosis	0.000654	0.00312	CcSEcCtD
Saxagliptin—Infestation—Methylprednisolone—multiple sclerosis	0.000642	0.00306	CcSEcCtD
Saxagliptin—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000642	0.00306	CcSEcCtD
Saxagliptin—Face oedema—Prednisone—multiple sclerosis	0.000637	0.00304	CcSEcCtD
Saxagliptin—DPP8—cerebellum—multiple sclerosis	0.000619	0.0952	CbGeAlD
Saxagliptin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000613	0.00292	CcSEcCtD
Saxagliptin—Hypersensitivity—Cladribine—multiple sclerosis	0.00061	0.00291	CcSEcCtD
Saxagliptin—Asthenia—Cladribine—multiple sclerosis	0.000594	0.00283	CcSEcCtD
Saxagliptin—Pruritus—Cladribine—multiple sclerosis	0.000585	0.00279	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000581	0.00277	CcSEcCtD
Saxagliptin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000567	0.00271	CcSEcCtD
Saxagliptin—Myalgia—Mitoxantrone—multiple sclerosis	0.000567	0.00271	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisone—multiple sclerosis	0.000559	0.00267	CcSEcCtD
Saxagliptin—DPP9—brain—multiple sclerosis	0.000552	0.0849	CbGeAlD
Saxagliptin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00055	0.00263	CcSEcCtD
Saxagliptin—Dizziness—Cladribine—multiple sclerosis	0.000547	0.00261	CcSEcCtD
Saxagliptin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000544	0.0026	CcSEcCtD
Saxagliptin—Infection—Mitoxantrone—multiple sclerosis	0.00054	0.00258	CcSEcCtD
Saxagliptin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000533	0.00254	CcSEcCtD
Saxagliptin—Abdominal pain—Azathioprine—multiple sclerosis	0.000532	0.00254	CcSEcCtD
Saxagliptin—Skin disorder—Mitoxantrone—multiple sclerosis	0.000528	0.00252	CcSEcCtD
Saxagliptin—Vomiting—Cladribine—multiple sclerosis	0.000526	0.00251	CcSEcCtD
Saxagliptin—Erectile dysfunction—Prednisone—multiple sclerosis	0.000525	0.00251	CcSEcCtD
Saxagliptin—Rash—Cladribine—multiple sclerosis	0.000522	0.00249	CcSEcCtD
Saxagliptin—Dermatitis—Cladribine—multiple sclerosis	0.000521	0.00249	CcSEcCtD
Saxagliptin—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000521	0.00248	CcSEcCtD
Saxagliptin—Headache—Cladribine—multiple sclerosis	0.000518	0.00247	CcSEcCtD
Saxagliptin—DPP8—brain—multiple sclerosis	0.000503	0.0773	CbGeAlD
Saxagliptin—Malnutrition—Methylprednisolone—multiple sclerosis	0.000502	0.00239	CcSEcCtD
Saxagliptin—Angioedema—Prednisolone—multiple sclerosis	0.0005	0.00238	CcSEcCtD
Saxagliptin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000496	0.00237	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000496	0.00236	CcSEcCtD
Saxagliptin—Nausea—Cladribine—multiple sclerosis	0.000491	0.00235	CcSEcCtD
Saxagliptin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000479	0.00228	CcSEcCtD
Saxagliptin—Fatigue—Mitoxantrone—multiple sclerosis	0.000469	0.00224	CcSEcCtD
Saxagliptin—Pancreatitis—Methotrexate—multiple sclerosis	0.000467	0.00223	CcSEcCtD
Saxagliptin—Angioedema—Triamcinolone—multiple sclerosis	0.000459	0.00219	CcSEcCtD
Saxagliptin—Angioedema—Methylprednisolone—multiple sclerosis	0.000458	0.00219	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000446	0.00213	CcSEcCtD
Saxagliptin—Dizziness—Azathioprine—multiple sclerosis	0.000445	0.00212	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000445	0.00212	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000443	0.00211	CcSEcCtD
Saxagliptin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000439	0.00209	CcSEcCtD
Saxagliptin—Urticaria—Mitoxantrone—multiple sclerosis	0.000432	0.00206	CcSEcCtD
Saxagliptin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00043	0.00205	CcSEcCtD
Saxagliptin—Myalgia—Triamcinolone—multiple sclerosis	0.000428	0.00204	CcSEcCtD
Saxagliptin—Vomiting—Azathioprine—multiple sclerosis	0.000428	0.00204	CcSEcCtD
Saxagliptin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000427	0.00204	CcSEcCtD
Saxagliptin—Myalgia—Methylprednisolone—multiple sclerosis	0.000427	0.00204	CcSEcCtD
Saxagliptin—Infestation NOS—Methotrexate—multiple sclerosis	0.000425	0.00203	CcSEcCtD
Saxagliptin—Infestation—Methotrexate—multiple sclerosis	0.000425	0.00203	CcSEcCtD
Saxagliptin—Rash—Azathioprine—multiple sclerosis	0.000424	0.00202	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000424	0.00202	CcSEcCtD
Saxagliptin—Dermatitis—Azathioprine—multiple sclerosis	0.000424	0.00202	CcSEcCtD
Saxagliptin—Headache—Azathioprine—multiple sclerosis	0.000421	0.00201	CcSEcCtD
Saxagliptin—Angioedema—Dexamethasone—multiple sclerosis	0.000417	0.00199	CcSEcCtD
Saxagliptin—Angioedema—Betamethasone—multiple sclerosis	0.000417	0.00199	CcSEcCtD
Saxagliptin—Immune system disorder—Prednisone—multiple sclerosis	0.000412	0.00197	CcSEcCtD
Saxagliptin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00041	0.00196	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000409	0.00195	CcSEcCtD
Saxagliptin—Infection—Triamcinolone—multiple sclerosis	0.000408	0.00195	CcSEcCtD
Saxagliptin—Infection—Methylprednisolone—multiple sclerosis	0.000407	0.00194	CcSEcCtD
Saxagliptin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000401	0.00191	CcSEcCtD
Saxagliptin—Nausea—Azathioprine—multiple sclerosis	0.0004	0.00191	CcSEcCtD
Saxagliptin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000398	0.0019	CcSEcCtD
Saxagliptin—Malnutrition—Prednisone—multiple sclerosis	0.000397	0.0019	CcSEcCtD
Saxagliptin—Asthenia—Mitoxantrone—multiple sclerosis	0.00039	0.00186	CcSEcCtD
Saxagliptin—Myalgia—Betamethasone—multiple sclerosis	0.000388	0.00185	CcSEcCtD
Saxagliptin—Myalgia—Dexamethasone—multiple sclerosis	0.000388	0.00185	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000374	0.00178	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000373	0.00178	CcSEcCtD
Saxagliptin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000372	0.00178	CcSEcCtD
Saxagliptin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000372	0.00178	CcSEcCtD
Saxagliptin—Infection—Betamethasone—multiple sclerosis	0.00037	0.00176	CcSEcCtD
Saxagliptin—Infection—Dexamethasone—multiple sclerosis	0.00037	0.00176	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000365	0.00174	CcSEcCtD
Saxagliptin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000365	0.00174	CcSEcCtD
Saxagliptin—Angioedema—Prednisone—multiple sclerosis	0.000363	0.00173	CcSEcCtD
Saxagliptin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000361	0.00172	CcSEcCtD
Saxagliptin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00036	0.00172	CcSEcCtD
Saxagliptin—Urticaria—Prednisolone—multiple sclerosis	0.000354	0.00169	CcSEcCtD
Saxagliptin—Fatigue—Triamcinolone—multiple sclerosis	0.000354	0.00169	CcSEcCtD
Saxagliptin—Fatigue—Methylprednisolone—multiple sclerosis	0.000353	0.00168	CcSEcCtD
Saxagliptin—Vomiting—Mitoxantrone—multiple sclerosis	0.000346	0.00165	CcSEcCtD
Saxagliptin—Immune system disorder—Methotrexate—multiple sclerosis	0.000345	0.00164	CcSEcCtD
Saxagliptin—Rash—Mitoxantrone—multiple sclerosis	0.000343	0.00164	CcSEcCtD
Saxagliptin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000343	0.00163	CcSEcCtD
Saxagliptin—Headache—Mitoxantrone—multiple sclerosis	0.000341	0.00163	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000339	0.00162	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000339	0.00162	CcSEcCtD
Saxagliptin—Arthralgia—Prednisone—multiple sclerosis	0.000338	0.00161	CcSEcCtD
Saxagliptin—Myalgia—Prednisone—multiple sclerosis	0.000338	0.00161	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000336	0.0016	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000335	0.0016	CcSEcCtD
Saxagliptin—Malnutrition—Methotrexate—multiple sclerosis	0.000332	0.00158	CcSEcCtD
Saxagliptin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000329	0.00157	CcSEcCtD
Saxagliptin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000328	0.00156	CcSEcCtD
Saxagliptin—Dyspepsia—Betamethasone—multiple sclerosis	0.000328	0.00156	CcSEcCtD
Saxagliptin—Urticaria—Triamcinolone—multiple sclerosis	0.000326	0.00156	CcSEcCtD
Saxagliptin—Urticaria—Methylprednisolone—multiple sclerosis	0.000325	0.00155	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000324	0.00155	CcSEcCtD
Saxagliptin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000324	0.00154	CcSEcCtD
Saxagliptin—Nausea—Mitoxantrone—multiple sclerosis	0.000323	0.00154	CcSEcCtD
Saxagliptin—Infection—Prednisone—multiple sclerosis	0.000322	0.00154	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Saxagliptin—Fatigue—Dexamethasone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Saxagliptin—Fatigue—Betamethasone—multiple sclerosis	0.000321	0.00153	CcSEcCtD
Saxagliptin—Skin disorder—Prednisone—multiple sclerosis	0.000315	0.0015	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000304	0.00145	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000304	0.00145	CcSEcCtD
Saxagliptin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000302	0.00144	CcSEcCtD
Saxagliptin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000302	0.00144	CcSEcCtD
Saxagliptin—Urticaria—Dexamethasone—multiple sclerosis	0.000296	0.00141	CcSEcCtD
Saxagliptin—Urticaria—Betamethasone—multiple sclerosis	0.000296	0.00141	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000295	0.00141	CcSEcCtD
Saxagliptin—Dizziness—Prednisolone—multiple sclerosis	0.000295	0.00141	CcSEcCtD
Saxagliptin—Asthenia—Triamcinolone—multiple sclerosis	0.000294	0.0014	CcSEcCtD
Saxagliptin—Abdominal pain—Betamethasone—multiple sclerosis	0.000294	0.0014	CcSEcCtD
Saxagliptin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000294	0.0014	CcSEcCtD
Saxagliptin—Asthenia—Methylprednisolone—multiple sclerosis	0.000294	0.0014	CcSEcCtD
Saxagliptin—Pruritus—Triamcinolone—multiple sclerosis	0.00029	0.00139	CcSEcCtD
Saxagliptin—Pruritus—Methylprednisolone—multiple sclerosis	0.00029	0.00138	CcSEcCtD
Saxagliptin—Dyspepsia—Prednisone—multiple sclerosis	0.000285	0.00136	CcSEcCtD
Saxagliptin—Arthralgia—Methotrexate—multiple sclerosis	0.000283	0.00135	CcSEcCtD
Saxagliptin—Myalgia—Methotrexate—multiple sclerosis	0.000283	0.00135	CcSEcCtD
Saxagliptin—Rash—Prednisolone—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Saxagliptin—Dermatitis—Prednisolone—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Saxagliptin—Fatigue—Prednisone—multiple sclerosis	0.00028	0.00133	CcSEcCtD
Saxagliptin—Headache—Prednisolone—multiple sclerosis	0.00028	0.00133	CcSEcCtD
Saxagliptin—DPP4—nervous system—multiple sclerosis	0.000276	0.0425	CbGeAlD
Saxagliptin—Dizziness—Triamcinolone—multiple sclerosis	0.000271	0.00129	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000271	0.00129	CcSEcCtD
Saxagliptin—Dizziness—Methylprednisolone—multiple sclerosis	0.000271	0.00129	CcSEcCtD
Saxagliptin—Infection—Methotrexate—multiple sclerosis	0.000269	0.00128	CcSEcCtD
Saxagliptin—Asthenia—Dexamethasone—multiple sclerosis	0.000267	0.00127	CcSEcCtD
Saxagliptin—Asthenia—Betamethasone—multiple sclerosis	0.000267	0.00127	CcSEcCtD
Saxagliptin—DPP4—central nervous system—multiple sclerosis	0.000266	0.0409	CbGeAlD
Saxagliptin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000265	0.00127	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000265	0.00127	CcSEcCtD
Saxagliptin—Nausea—Prednisolone—multiple sclerosis	0.000265	0.00126	CcSEcCtD
Saxagliptin—Pruritus—Betamethasone—multiple sclerosis	0.000263	0.00126	CcSEcCtD
Saxagliptin—Pruritus—Dexamethasone—multiple sclerosis	0.000263	0.00126	CcSEcCtD
Saxagliptin—Skin disorder—Methotrexate—multiple sclerosis	0.000263	0.00126	CcSEcCtD
Saxagliptin—Vomiting—Triamcinolone—multiple sclerosis	0.000261	0.00124	CcSEcCtD
Saxagliptin—Vomiting—Methylprednisolone—multiple sclerosis	0.00026	0.00124	CcSEcCtD
Saxagliptin—Rash—Triamcinolone—multiple sclerosis	0.000259	0.00123	CcSEcCtD
Saxagliptin—Dermatitis—Triamcinolone—multiple sclerosis	0.000258	0.00123	CcSEcCtD
Saxagliptin—Rash—Methylprednisolone—multiple sclerosis	0.000258	0.00123	CcSEcCtD
Saxagliptin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000258	0.00123	CcSEcCtD
Saxagliptin—Urticaria—Prednisone—multiple sclerosis	0.000258	0.00123	CcSEcCtD
Saxagliptin—Headache—Triamcinolone—multiple sclerosis	0.000257	0.00123	CcSEcCtD
Saxagliptin—Headache—Methylprednisolone—multiple sclerosis	0.000256	0.00122	CcSEcCtD
Saxagliptin—Abdominal pain—Prednisone—multiple sclerosis	0.000256	0.00122	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000247	0.00118	CcSEcCtD
Saxagliptin—Dizziness—Betamethasone—multiple sclerosis	0.000246	0.00117	CcSEcCtD
Saxagliptin—Dizziness—Dexamethasone—multiple sclerosis	0.000246	0.00117	CcSEcCtD
Saxagliptin—Nausea—Triamcinolone—multiple sclerosis	0.000244	0.00116	CcSEcCtD
Saxagliptin—Nausea—Methylprednisolone—multiple sclerosis	0.000243	0.00116	CcSEcCtD
Saxagliptin—Hypersensitivity—Prednisone—multiple sclerosis	0.000239	0.00114	CcSEcCtD
Saxagliptin—Dyspepsia—Methotrexate—multiple sclerosis	0.000239	0.00114	CcSEcCtD
Saxagliptin—Vomiting—Dexamethasone—multiple sclerosis	0.000237	0.00113	CcSEcCtD
Saxagliptin—Vomiting—Betamethasone—multiple sclerosis	0.000237	0.00113	CcSEcCtD
Saxagliptin—Rash—Dexamethasone—multiple sclerosis	0.000235	0.00112	CcSEcCtD
Saxagliptin—Rash—Betamethasone—multiple sclerosis	0.000235	0.00112	CcSEcCtD
Saxagliptin—Dermatitis—Dexamethasone—multiple sclerosis	0.000235	0.00112	CcSEcCtD
Saxagliptin—Dermatitis—Betamethasone—multiple sclerosis	0.000235	0.00112	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000234	0.00112	CcSEcCtD
Saxagliptin—Fatigue—Methotrexate—multiple sclerosis	0.000234	0.00111	CcSEcCtD
Saxagliptin—Headache—Dexamethasone—multiple sclerosis	0.000233	0.00111	CcSEcCtD
Saxagliptin—Headache—Betamethasone—multiple sclerosis	0.000233	0.00111	CcSEcCtD
Saxagliptin—Asthenia—Prednisone—multiple sclerosis	0.000233	0.00111	CcSEcCtD
Saxagliptin—Pruritus—Prednisone—multiple sclerosis	0.000229	0.00109	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000222	0.00106	CcSEcCtD
Saxagliptin—Nausea—Dexamethasone—multiple sclerosis	0.000221	0.00106	CcSEcCtD
Saxagliptin—Nausea—Betamethasone—multiple sclerosis	0.000221	0.00106	CcSEcCtD
Saxagliptin—Urticaria—Methotrexate—multiple sclerosis	0.000215	0.00103	CcSEcCtD
Saxagliptin—Dizziness—Prednisone—multiple sclerosis	0.000214	0.00102	CcSEcCtD
Saxagliptin—Abdominal pain—Methotrexate—multiple sclerosis	0.000214	0.00102	CcSEcCtD
Saxagliptin—DPP4—brain—multiple sclerosis	0.000211	0.0325	CbGeAlD
Saxagliptin—Vomiting—Prednisone—multiple sclerosis	0.000206	0.000984	CcSEcCtD
Saxagliptin—Rash—Prednisone—multiple sclerosis	0.000204	0.000976	CcSEcCtD
Saxagliptin—Dermatitis—Prednisone—multiple sclerosis	0.000204	0.000975	CcSEcCtD
Saxagliptin—Headache—Prednisone—multiple sclerosis	0.000203	0.000969	CcSEcCtD
Saxagliptin—Hypersensitivity—Methotrexate—multiple sclerosis	0.0002	0.000953	CcSEcCtD
Saxagliptin—Asthenia—Methotrexate—multiple sclerosis	0.000194	0.000928	CcSEcCtD
Saxagliptin—Nausea—Prednisone—multiple sclerosis	0.000193	0.000919	CcSEcCtD
Saxagliptin—Pruritus—Methotrexate—multiple sclerosis	0.000192	0.000915	CcSEcCtD
Saxagliptin—SLC22A8—nervous system—multiple sclerosis	0.000182	0.028	CbGeAlD
Saxagliptin—Dizziness—Methotrexate—multiple sclerosis	0.000179	0.000855	CcSEcCtD
Saxagliptin—SLC22A8—central nervous system—multiple sclerosis	0.000175	0.0269	CbGeAlD
Saxagliptin—Vomiting—Methotrexate—multiple sclerosis	0.000172	0.000822	CcSEcCtD
Saxagliptin—Rash—Methotrexate—multiple sclerosis	0.000171	0.000815	CcSEcCtD
Saxagliptin—Dermatitis—Methotrexate—multiple sclerosis	0.000171	0.000815	CcSEcCtD
Saxagliptin—Headache—Methotrexate—multiple sclerosis	0.00017	0.00081	CcSEcCtD
Saxagliptin—Nausea—Methotrexate—multiple sclerosis	0.000161	0.000768	CcSEcCtD
Saxagliptin—ABCC1—cerebellum—multiple sclerosis	0.000147	0.0226	CbGeAlD
Saxagliptin—SLC22A8—brain—multiple sclerosis	0.000139	0.0214	CbGeAlD
Saxagliptin—ABCC1—brain—multiple sclerosis	0.000119	0.0184	CbGeAlD
Saxagliptin—CYP3A4—nervous system—multiple sclerosis	9.01e-05	0.0139	CbGeAlD
Saxagliptin—CYP3A4—central nervous system—multiple sclerosis	8.67e-05	0.0133	CbGeAlD
